SCHEMBL11201711

SCHEMBL11201711

C=CCOc1ccccc1OCC(O)CNC(C)(C)C

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 11/20 0.70
ADRB1 P08588 8/20 0.70
CYP2D6 P10635 4/20 0.70
HTR1A P08908 3/20 0.70
CYP1A2 P05177 3/20 0.70
SLC6A4 P31645 2/20 0.70
ADRA1A P35348 2/20 0.70
LMNA P02545 2/20 0.70
SLC22A1 O15245 1/20 0.70
HTR2A P28223 1/20 0.70
MAPT P10636 1/20 0.64
ADRA2A P08913 2/20 0.61
ADRA2B P18089 1/20 0.61
MAOA P21397 1/20 0.61
HTR2B P41595 1/20 0.61
ADRB3 P13945 5/20 0.58
USP2 O75604 1/20 0.57
CHRM1 P11229 1/20 0.57
CYP2C9 P11712 1/20 0.57
DRD1 P21728 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11870445 0.89 MAPT (0.78) ADRB2ADRB1CYP2D6HTR1ACYP1A2
SCHEMBL11135761 0.87 ADRB2 (0.64) ADRB2ADRB1CYP2D6HTR1ACYP1A2
Hydrochloric Acid SCHEMBL11870616 0.87 MAPT (0.81) ADRB2ADRB1CYP2D6HTR1ACYP1A2
SCHEMBL7310963 0.85 MAPT (0.56) ADRB2ADRB1CYP2D6HTR1ACYP1A2
SCHEMBL11845793 0.84 ALDH1A1 (0.74) ADRB2ADRB1CYP2D6HTR1ACYP1A2
SCHEMBL11860104 0.83 ADRB2 (0.75) ADRB2ADRB1CYP2D6HTR1ACYP1A2
Hydrochloric Acid SCHEMBL11226416 0.83 ALDH1A1 (0.73) ADRB2ADRB1CYP2D6HTR1ACYP1A2
SCHEMBL7308129 0.82 MAPT (0.53) ADRB2ADRB1CYP2D6HTR1ACYP1A2
Oxprenolol SCHEMBL16311 0.82 ADRB2 (1.00) ADRB2ADRB1CYP2D6HTR1ACYP1A2
Oxprenolol SCHEMBL16310 0.82 ADRB2 (1.00) ADRB2ADRB1CYP2D6HTR1ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4391980-A FOR INVERSION OF CONFIGURATION OF OPTICALLY ACTIVE COMPOUNDS CIBA-GEIGY CORPORATION (US) 1983-07-05 US disclosed
US-4294966-A SALT FORMATION CIBA-GEIGY CORPORATION (US) 1981-10-13 US disclosed
EP-0007605-A1 A process for inverting the configuration in optically active compounds and optically active intermediate compounds and their salts required therefor CIBA-GEIGY AG (CH) 1980-02-06 EP disclosed
US-4161530-A CYCLIC SUBSTITUTED AMINO ALCOHOL BETA-RECEPTOR-BLOCKING AGENT AND TRYPTOPHANE CIBA-GEIGY CORPORATION (US) 1979-07-17 US disclosed
US-3937834-A ALPHA-RECEPTOR BLOCKER, BETA-RECEPTOR BLOCKER, HIGH BLOOD PRESSURE, ANGINA PECTORIS CIBA-GEIGY CORPORATION (US) 1976-02-10 US disclosed